Overview
- Editors:
-
-
A. L. Burlingame
-
University of California, San Francisco, USA
-
Steven A. Carr
-
SmithKline Beecham Pharmaceuticals, King of Prussia, USA
Access this book
Other ways to access
Table of contents (26 chapters)
-
- Jane E. Thomas-Oates, Jorrit D. J. van den Berg, Koen M. G. M. van der Drift, Geert Jan Rademaker, Guido V. Bloemberg, Isabel M. López-Lara et al.
Pages 385-401
-
- William Melaugh, Jeffrey J. Engstrom, Seppo Auriola, Nancy J. Phillips, Bradford W. Gibson
Pages 403-424
-
- Deanne M. Dulik, William H. Schaefer, Joseph Bordas-Nagy, Richard C. Simpson, Darlene M. Murphy, Gerald R. Rhodes
Pages 425-449
-
- Robert C. Murphy, Kathleen A. Harrison
Pages 451-476
-
- Kenneth W. Turteltaub, John S. Vogel
Pages 477-495
-
- P. F. Crain, J. M. Gregson, J. A. McCloskey, C. C. Nelson, J. M. Peltier, D. R. Phillips et al.
Pages 497-517
-
- Charles R. Cantor, Natalia Broude, Takeshi Sano, Marek Przetakiewicz, Cassandra L. Smith
Pages 519-533
-
Back Matter
Pages 535-570
About this book
Leading practitioners describe in detail advanced methods of mass spectrometry used in structural characterization of biomacromolecules of both natural and recombinant origin. They demonstrate by example how these methodologies can solve a wide array of real-world problems in protein biochemistry, immunology, and glycobiology, as well as for human bacterial pathogens, lipids, and nucleic acids. The book offers a unique opportunity to learn these techniques that are revolutionizing the field. Its authoritative assessment in the context of how to solve important and challenging problems in bioscience and medicine ensures a competitive advantage for today's researchers.
Reviews
The articles are uniformly well written...In summary, the book best serves the community interested in the characterization of proteins by mass spectrometer methods, but it contains valuable insights for analysis of other biomolecules as well.- Quarterly Review of Biology
Editors and Affiliations
-
University of California, San Francisco, USA
A. L. Burlingame
-
SmithKline Beecham Pharmaceuticals, King of Prussia, USA
Steven A. Carr